Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C

Aim Although there is much evidence of an antitumor effect of pegylated interferon (IFN)‐α‐based treatment, limited data is available about that of IFN‐β‐based treatment. Our goal was to evaluate the impact of IFN‐β plus ribavirin (RBV) treatment on the suppression of hepatocellular carcinoma (HCC)....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology research 2016-03, Vol.46 (3), p.E174-E180
Hauptverfasser:	Ikezaki, Hiroaki, Nomura, Hideyuki, Furusyo, Norihiro, Ogawa, Eiichi, Kajiwara, Eiji, Takahashi, Kazuhiro, Kawano, Akira, Maruyama, Toshihiro, Tanabe, Yuichi, Satoh, Takeaki, Nakamuta, Makoto, Kotoh, Kazuhiro, Azuma, Koichi, Dohmen, Kazufumi, Shimoda, Shinji, Hayashi, Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	advanced fibrosis antitumor beta-interferon hepatocellular carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!